# Abuse Liability of Pregabalin and Its Effects on Benzodiazepine Withdrawal Symptoms

> **NCT02423018** · PHASE4 · TERMINATED · sponsor: **Centre for Addiction and Mental Health** · enrollment: 1 (actual)

## Conditions studied

- Substance-Related Disorders

## Interventions

- **DRUG:** Pregabalin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02423018
- **Lead sponsor:** Centre for Addiction and Mental Health
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-04
- **Primary completion:** 2016-03
- **Final completion:** 2016-03
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Low enrollment.
- **Last updated:** 2016-03-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02423018

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02423018, "Abuse Liability of Pregabalin and Its Effects on Benzodiazepine Withdrawal Symptoms". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02423018. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*